The Twilight Zone of Hong Kong Equities: Delistings, Pivots, and Frozen TickersGlobal Report·Aug 11 at 04:43 AM01858-2.93%02570-5.07%
The Strategic Divergence: When Real Estate Pivots to AI and Legacy Brands Seek New MoatsGlobal Report·Jul 15 at 04:14 AM01800-1.21%01798-0.85%
Hong Kong Market Tests Recovery as Galaxy Entertainment Braces for Macau Slump and Tech ExpandsGlobal Report·Jul 7 at 05:38 AM06896-2.77%01907+4.32%
In the report, GOLDEN THROAT's annual net profit is 251 million RMB, a decrease of 21.2%, with a final dividend of 34 Hong Kong centsAASTOCKS·Mar 29 at 07:14 AM512010-1.50%520880-0.22%
Golden Throat Profit Falls Over 20% in 2025 but Dividend MaintainedTip Ranks·Mar 27 at 12:51 PM06896-2.77%
GOLDEN THROAT released its interim results, with a net profit attributable to the parent company of 83.674 million yuan, a year-on-year decrease of 37.65%Zhitong·Aug 28, 2025 at 07:13 AM06896-2.77%
GOLDEN THROAT issues profit warning, expects a decrease of approximately 37% in profit for the first half of the yearZhitong·Aug 11, 2025 at 09:46 AM06896-2.77%
GOLDEN THROAT throat lozenge products received certification from the Ministry of Health of UzbekistanAASTOCKS·Jul 31, 2025 at 03:23 AM06896-2.77%
Hong Kong Stock Concept Tracking | The Trend of COVID-19 Infections is Rising, Antiviral Drug Companies Attract Attention (Including Concept Stocks)Zhitong·May 15, 2025 at 10:05 PM000756+0.64%00719+0.08%
Understanding the Market | Some pharmaceutical stocks rose in early trading, with SHANDONG XINHUA surging over 10% as COVID-19 infections show an upward trendZhitong·May 15, 2025 at 09:15 PM01530-0.94%000756+0.64%
